Immunotherapy for liposarcoma: emerging opportunities and challenges.
Sign Up to like & getrecommendations! Published in 2022 at "Future oncology"
DOI: 10.2217/fon-2021-1549
Abstract: Liposarcoma (LPS) is a rare adipocyte-derived malignancy accounting for 20% of all soft tissue sarcomas. Although surgery and chemotherapy are the standard treatment for LPS, the large tumor burden and high recurrence rate make it… read more here.
Keywords: immunotherapy; liposarcoma emerging; liposarcoma; emerging opportunities ... See more keywords